DE10299001I1 - Erythromycinderivate, ihre Verfahren zur Herstellung und ihre Verwendung als Arzneimittel. - Google Patents

Erythromycinderivate, ihre Verfahren zur Herstellung und ihre Verwendung als Arzneimittel.

Info

Publication number
DE10299001I1
DE10299001I1 DE2002199001 DE10299001C DE10299001I1 DE 10299001 I1 DE10299001 I1 DE 10299001I1 DE 2002199001 DE2002199001 DE 2002199001 DE 10299001 C DE10299001 C DE 10299001C DE 10299001 I1 DE10299001 I1 DE 10299001I1
Authority
DE
Germany
Prior art keywords
medicaments
preparation
methods
erythromycin derivatives
erythromycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE2002199001
Other languages
English (en)
Other versions
DE10299001I2 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of DE10299001I1 publication Critical patent/DE10299001I1/de
Publication of DE10299001I2 publication Critical patent/DE10299001I2/de
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
DE2002199001 1994-05-03 1995-05-02 Erythromycinderivate, ihre Verfahren zur Herstellung und ihre Verwendung als Arzneimittel Active DE10299001I2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9405368A FR2719587B1 (fr) 1994-05-03 1994-05-03 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Publications (2)

Publication Number Publication Date
DE10299001I1 true DE10299001I1 (de) 2012-07-05
DE10299001I2 DE10299001I2 (de) 2012-07-05

Family

ID=9462785

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69505296T Expired - Lifetime DE69505296T2 (de) 1994-05-03 1995-05-02 Erythromycinderivate, ihre Verfahren zur Herstellung und ihre Verwendung als Arzneimittel
DE2002199001 Active DE10299001I2 (de) 1994-05-03 1995-05-02 Erythromycinderivate, ihre Verfahren zur Herstellung und ihre Verwendung als Arzneimittel

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69505296T Expired - Lifetime DE69505296T2 (de) 1994-05-03 1995-05-02 Erythromycinderivate, ihre Verfahren zur Herstellung und ihre Verwendung als Arzneimittel

Country Status (43)

Country Link
US (2) US5635485A (de)
EP (1) EP0680967B1 (de)
JP (4) JP2992540B2 (de)
KR (1) KR100312267B1 (de)
CN (2) CN1052984C (de)
AP (1) AP558A (de)
AT (1) ATE172203T1 (de)
AU (1) AU684027B2 (de)
BG (1) BG63087B1 (de)
BR (1) BR9507700A (de)
CA (1) CA2189271C (de)
CZ (1) CZ293455B6 (de)
DE (2) DE69505296T2 (de)
DK (1) DK0680967T3 (de)
DZ (1) DZ1878A1 (de)
EE (1) EE03263B1 (de)
ES (1) ES2122472T3 (de)
FI (1) FI111263B (de)
FR (1) FR2719587B1 (de)
GE (1) GEP19991538B (de)
HK (1) HK1010732A1 (de)
HU (2) HU227493B1 (de)
IL (1) IL113245A (de)
LU (1) LU90872I2 (de)
LV (1) LV11739B (de)
MA (1) MA23534A1 (de)
MD (1) MD1233C2 (de)
NL (1) NL300077I1 (de)
NO (2) NO308853B1 (de)
NZ (1) NZ285416A (de)
OA (1) OA10319A (de)
PL (1) PL182034B1 (de)
RO (1) RO113350B1 (de)
RU (1) RU2144036C1 (de)
SI (1) SI0680967T1 (de)
SK (1) SK281707B6 (de)
TJ (1) TJ313B (de)
TN (1) TNSN95049A1 (de)
TW (1) TW341573B (de)
UA (1) UA51618C2 (de)
WO (1) WO1995029929A1 (de)
YU (1) YU49235B (de)
ZA (1) ZA953501B (de)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5708005A (en) * 1995-06-27 1998-01-13 Takeda Chemical Industries, Ltd. Quinolines, their production and use
FR2742757B1 (fr) 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
CN100441591C (zh) * 1996-09-04 2008-12-10 艾博特公司 酮基内酯类化合物，其用途和制备方法以及药用组合物
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
US5780605A (en) * 1997-09-08 1998-07-14 Abbott Laboratories 6,9-bridged erythromycin derivatives
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2781484B1 (fr) * 1998-07-21 2001-08-10 Hoechst Marion Roussel Inc Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
ATE298761T1 (de) 1998-09-22 2005-07-15 Pfizer Prod Inc Carbamat- und carbazatketolidantibiotika
FR2785612A1 (fr) * 1998-11-10 2000-05-12 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
TW526202B (en) * 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
DE69933897T2 (de) 1998-12-10 2007-03-15 Pfizer Products Inc., Groton Carbamat- und Carbazatketolid-Antibiotika
TR200102128T2 (tr) * 1999-01-27 2001-12-21 Pfizer Products Inc. Ketolid antibiyotikler
FR2789392B1 (fr) * 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
IL145976A0 (en) 1999-04-16 2002-07-25 Ortho Mcneil Pharm Inc Ketolide antibacterials
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
WO2000063225A2 (en) 1999-04-16 2000-10-26 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6939861B2 (en) * 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
WO2000071557A1 (en) * 1999-05-24 2000-11-30 Pfizer Products Inc. 13-methyl-erythromycin derivatives
FR2797875B1 (fr) * 1999-08-26 2001-10-19 Hoechst Marion Roussel Inc Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
EP1313751B1 (de) * 2000-08-22 2008-09-17 Basilea Pharmaceutica AG Neue macrolide mit antibakterieller wirkung
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
CA2451391A1 (en) * 2001-07-03 2003-01-16 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
US8063021B2 (en) * 2002-01-17 2011-11-22 Kosan Biosciences Incorporated Ketolide anti-infective compounds
US6995143B2 (en) 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
RU2330858C2 (ru) 2002-07-08 2008-08-10 Глаксомитклайн Истраживацки Центар Загреб Д.О.О. Новые соединения, составы и способы лечения воспалительных заболеваний и состояний
ATE429441T1 (de) 2002-07-08 2009-05-15 Glaxosmithkline Zagreb Hybridmoleküle von makroliden mit steroidalen/nicht-steroidalen antientzündlich aktiven molekülen
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
US6916934B2 (en) * 2003-02-11 2005-07-12 Aventis Pharma Deutschland Gmbh Process for preparing pyridine-substituted amino ketal derivatives
EP1638549A4 (de) * 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc Neue antibakterielle mittel
WO2004096823A2 (en) * 2003-04-25 2004-11-11 Chiron Corporation Novel ketolide derivatives
US20050101548A1 (en) * 2003-09-12 2005-05-12 Xiaodong Lin Antimicrobial derivatives
GB0402578D0 (en) * 2004-02-05 2004-03-10 Cambridge Theranostics Ltd Methods of treatment of atherosclerosis
US8202843B2 (en) 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
PL1742957T3 (pl) * 2004-04-28 2008-05-30 Alembic Ltd Sposób otrzymywania telitromycyny
JP2008508322A (ja) * 2004-07-28 2008-03-21 ランバクシー ラボラトリーズ リミテッド 抗菌剤としてのケトライド誘導体
WO2006046112A2 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
UA85937C2 (uk) * 2004-12-21 2009-03-10 Пфайзер Продактс Інк. Макроліди
WO2006085507A1 (ja) * 2005-02-08 2006-08-17 Murata Manufacturing Co., Ltd. 表面実装型負特性サーミスタ
FR2882522B1 (fr) 2005-02-25 2007-04-13 Aventis Pharma Sa Composition pharmaceutique solide comprenant de la telithromycine
WO2006129257A2 (en) * 2005-05-30 2006-12-07 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
WO2007049296A2 (en) * 2005-10-28 2007-05-03 Alembic Limited Amorphous form of telithromycin
US20070167382A1 (en) * 2005-11-15 2007-07-19 Nina Finkelstein Crystalline and amorphous forms of telithromycin
EP1954294A2 (de) * 2005-11-23 2008-08-13 Ranbaxy Laboratories Limited Verwendung von makrolid-derivaten zur behandlung von akne
WO2007060518A2 (en) * 2005-11-23 2007-05-31 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
WO2007060618A2 (en) * 2005-11-23 2007-05-31 Ranbaxy Laboratories Limited Macrolides derivatives as antibacterial agents
US7595300B2 (en) 2005-12-13 2009-09-29 Kosan Biosciences Incorporated 7-quinolyl ketolide antibacterial agents
GB0600238D0 (en) * 2006-01-06 2006-02-15 Sandoz Ag Organic compounds
EP1985620A4 (de) * 2006-02-07 2012-08-15 Taisho Pharmaceutical Co Ltd 10a-AZALIDVERBINDUNG
KR20090042971A (ko) 2006-08-24 2009-05-04 욱크하르트 리서치 센터 항미생물 활성을 갖는 신규한 마크로라이드 및 케토라이드
WO2008023383A1 (en) * 2006-08-25 2008-02-28 Alembic Limited Novel process for the preparation of telithromycin
ES2306590B1 (es) * 2006-12-15 2009-08-07 Ercros Industrial,S .A. Formas cristalinas i y ii de telitromicina.
WO2009019868A1 (ja) 2007-08-06 2009-02-12 Taisho Pharmaceutical Co., Ltd. １０ａ、１２位架橋型１０ａ－アザライド化合物
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
CN104605647B (zh) 2007-09-20 2019-10-08 赫尔曼米勒有限公司 载荷支撑结构
US9453042B2 (en) 2007-10-25 2016-09-27 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
WO2009053259A1 (en) * 2007-10-25 2009-04-30 Sandoz Ag Process for the production of telithromycin
US8299035B2 (en) * 2008-05-15 2012-10-30 Taisho Pharmaceutucal Co., Ltd. 10a-azalide compound having 4-membered ring structure
AU2009308182B2 (en) * 2008-10-24 2016-05-19 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US8541420B2 (en) 2009-05-27 2013-09-24 Wockhardt Ltd. Ketolide compounds having antimicrobial activity
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
EP2475253B1 (de) 2009-09-10 2016-10-26 Cempra Pharmaceuticals, Inc. Verfahren zur behandlung von malaria, tuberkulose und mac-erkrankungen
CA2793884C (en) 2010-03-22 2019-09-10 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
DK2571506T3 (en) 2010-05-20 2017-08-28 Cempra Pharmaceuticals Inc PROCEDURES FOR THE MANUFACTURE OF MACROLIDES AND KETOLIDES AND INTERMEDIATES
KR20130120458A (ko) * 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
DK2673285T3 (en) 2010-12-09 2017-10-16 Wockhardt Ltd Ketolide compounds
AR085286A1 (es) 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
US9206214B2 (en) 2011-03-01 2015-12-08 Wockhardt Ltd. Process for preparation of ketolide intermediates
US8993739B2 (en) 2011-03-22 2015-03-31 Wockhardt Ltd. Process for preparation of ketolide compounds
US10188674B2 (en) 2012-03-27 2019-01-29 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
CA2905975A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (zh) 2013-03-15 2015-12-23 森普拉制药公司 用于制备大环内酯抗菌剂的收敛方法
CN105524132B (zh) * 2014-09-30 2019-07-02 中国医学科学院药物研究所 含有喹啉取代基的红霉素a酮内酯类抗生素衍生物、其制备方法及应用
DE102015201783A1 (de) 2015-02-02 2016-08-04 Friedrich Baur Verfahren zur Herstellung eines Füllstoffs aus Textilfasern sowie Textil mit einem solchen Füllstoff
CN107129514B (zh) * 2016-03-02 2019-12-13 中国医学科学院药物研究所 红霉素a酮内酯类抗生素衍生物、其制备方法及应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
EP0034116A3 (de) * 1980-02-11 1981-09-02 Berlex Laboratories, Inc. N-(3-Phenoxy-2-hydroxypropyl)benzimidazol-1-alkanamine
US4434174A (en) * 1980-02-11 1984-02-28 Berlex Laboratories, Inc. Treating cardiovascular diseases with N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
US4568687A (en) * 1983-02-28 1986-02-04 American Cyanamid Company N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical compositions
ZA84949B (en) * 1983-04-06 1984-09-26 American Cyanamid Co Substituted-n-(2-4-(1h-imidazol-1-yl)alkyl)substituted amides
US4489089A (en) * 1983-04-06 1984-12-18 American Cyanamid Company Substituted N-[ω-(1H-imidazol-1-yl)alkyl]-amides
AU573828B2 (en) * 1984-05-17 1988-06-23 E.R. Squibb & Sons, Inc. Tetrahydronaphthalenols
GB8425104D0 (en) * 1984-10-04 1984-11-07 Ici America Inc Amide derivatives
DE3540376A1 (de) * 1985-11-14 1987-05-21 Bayer Ag Verfahren zur inhibierung der wasserstoffinduzierten korrosion von metallischen werkstoffen
ES2054684T3 (es) * 1986-10-29 1994-08-16 Pfizer Procedimientos para la preparacion de 2-(1-pentil-3-guanidino)-4-(2-metil-4-imidazolil) tiazol y el dihidrocloruro trihidratado cristalino del mismo.
DE3930669A1 (de) * 1989-09-14 1991-03-28 Basf Ag Verfahren zur herstellung von uretdiongruppen aufweisenden polyisocyanaten
JP2899028B2 (ja) * 1989-12-01 1999-06-02 協和醗酵工業株式会社 ジベンゾオキセピン誘導体
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
ATE157368T1 (de) * 1990-11-28 1997-09-15 Taisho Pharmaceutical Co Ltd 6-0-methylerythromycin a-derivat
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
TW370529B (en) * 1992-12-17 1999-09-21 Pfizer Pyrazolopyrimidines
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates

Also Published As

Publication number Publication date
CZ293455B6 (cs) 2004-05-12
TJ313B (en) 2001-08-06
NZ285416A (en) 1997-07-27
JP4750755B2 (ja) 2011-08-17
UA51618C2 (uk) 2002-12-16
DK0680967T3 (da) 1999-06-23
FI964395A0 (fi) 1996-10-31
NO964654D0 (no) 1996-11-04
CZ321496A3 (en) 1997-08-13
HUT75698A (en) 1997-05-28
JPH11152296A (ja) 1999-06-08
TW341573B (en) 1998-10-01
DE69505296T2 (de) 1999-04-22
KR100312267B1 (ko) 2002-06-22
FR2719587A1 (fr) 1995-11-10
NO964654L (no) 1996-11-04
BG63087B1 (bg) 2001-03-30
CN1229082A (zh) 1999-09-22
JP3998828B2 (ja) 2007-10-31
US6100404A (en) 2000-08-08
PL182034B1 (pl) 2001-10-31
AU2449995A (en) 1995-11-29
JP4658902B2 (ja) 2011-03-23
ATE172203T1 (de) 1998-10-15
IL113245A0 (en) 1995-07-31
ES2122472T3 (es) 1998-12-16
CA2189271C (fr) 2005-12-27
EE03263B1 (et) 2000-04-17
MA23534A1 (fr) 1995-12-31
SK281707B6 (sk) 2001-07-10
LU90872I2 (fr) 2002-03-12
SK140296A3 (en) 1998-04-08
HU219599B (hu) 2001-05-28
PL317071A1 (en) 1997-03-03
RO113350B1 (ro) 1998-06-30
YU49235B (sh) 2004-12-31
HU227493B1 (en) 2011-07-28
HU9603038D0 (en) 1997-01-28
FR2719587B1 (fr) 1996-07-12
SI0680967T1 (en) 1999-02-28
WO1995029929A1 (fr) 1995-11-09
CA2189271A1 (fr) 1995-11-09
CN1052984C (zh) 2000-05-31
HK1010732A1 (en) 1999-06-25
DE10299001I2 (de) 2012-07-05
MX9605208A (es) 1997-09-30
HU9904687D0 (en) 2000-03-28
JP2007045847A (ja) 2007-02-22
AU684027B2 (en) 1997-11-27
GEP19991538B (en) 1999-03-05
BG100951A (en) 1997-08-29
CN1088709C (zh) 2002-08-07
AP558A (en) 1996-11-07
AP9500744A0 (en) 1995-07-31
MD1233B1 (en) 1999-05-31
NO308853B1 (no) 2000-11-06
MD1233C2 (ro) 2000-10-31
FI964395A (fi) 1996-10-31
DZ1878A1 (fr) 2002-02-17
TNSN95049A1 (fr) 1996-02-06
EP0680967A1 (de) 1995-11-08
BR9507700A (pt) 1997-08-19
NL300077I1 (nl) 2002-03-01
FI111263B (fi) 2003-06-30
JPH0853489A (ja) 1996-02-27
DE69505296D1 (de) 1998-11-19
EP0680967B1 (de) 1998-10-14
JP2007269810A (ja) 2007-10-18
YU27095A (sh) 1998-05-15
US5635485A (en) 1997-06-03
NO2001027I1 (no) 2002-01-28
LV11739B (en) 1997-08-20
CN1151746A (zh) 1997-06-11
JP2992540B2 (ja) 1999-12-20
ZA953501B (en) 1996-05-02
LV11739A (lv) 1997-04-20
IL113245A (en) 1999-11-30
RU2144036C1 (ru) 2000-01-10
OA10319A (fr) 1997-10-07

Similar Documents

Publication Publication Date Title
DE10299001I1 (de) Erythromycinderivate, ihre Verfahren zur Herstellung und ihre Verwendung als Arzneimittel.
DE69529934T2 (de) Erythromycin-Derivate, Verfahren zur Herstellung und ihre Verwendung als Arzneimittel
ATE258549T1 (de) Oxazolidindion-derivate, ihre herstellung und verwendung
ATE247099T1 (de) Sulfonamid-derivate, verfahren zur ihrer herstellung und ihre verwendung als arzneimittel
DE10399006I2 (de) Tetracyclische Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung.
DE69016125D1 (de) Chinolin-Derivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel.
DE69712610T2 (de) Erythramicin-derivate, ihre verfahren zur herstellung und ihre verwendung als arzneimittel
DE59814365D1 (de) Substituierte Isochinolin-3-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
DE122008000020I1 (de) Disubstituierte bicyclische heterocyclen, ihre herstellung und ihre verwendung als arzneimittel
DE59706602D1 (de) 3-Hydroxy-Pyridin-2-carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel
DE69909577D1 (de) Derivate von Erythromycin, ihr Verfahren zur Herstellung, und ihre Verwendung als Arzneimittel
DE59707976D1 (de) Neue guanidinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69027170T2 (de) Uracilderivate, ihre Herstellung und ihre Verwendung
DE59610963D1 (de) Neue phenylamidinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE59711704D1 (de) Neue carbonsäurederivate, ihre herstellung und verwendung
DE69514398D1 (de) 13-Substituierte Milbemycinderivate, ihre Herstellung und Verwendung
ATE212346T1 (de) 3-substituierte tetrahydropyridopyrimidinon- derivate, ihre herstellung und verwendung
DE59506347D1 (de) Zirkondioxidpulver, Verfahren zu seiner Herstellung und Verwendung
DE59501950D1 (de) Isolongifolanol-Derivate, ihre Herstellung und ihre Verwendung
ATE225798T1 (de) Erythromycin-derivate, verfahren zur herstellung und verwendung als arzneimittel
ATE198192T1 (de) Benzolsulfonamidderivate, ihre herstellung und ihre therapeutische verwendung
DE59800568D1 (de) Benzoxazindionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE59606132D1 (de) Neue carbonsäurederivate, ihre herstellung und verwendung
DE59405814D1 (de) Neue leukotrien-b4-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE59706478D1 (de) Chromanyl-ascorbinsäurederivate, deren Herstellung und Verwendung